Exelixis (EXEL) Change in Inventory (2013 - 2026)
Exelixis' (EXEL) quarterly Change in Inventory came in at $3.4 million in Q2 2026, up 4673.24% year-on-year from $71000.0 in Q2 2025, and up 124.55% quarter-over-quarter from -$13.8 million in Q1 2026.
Exelixis (EXEL) Change in Inventory (2013 - 2026) Analysis & Trends
Exelixis' Change in Inventory history runs 14 years deep, the most recent figure standing at $3.4 million for Q2 2026.
- On a quarterly basis, Change in Inventory rose 4673.24% year-over-year to $3.4 million in Q2 2026; TTM through Apr 2026 was -$8.9 million, a 142.9% decrease from a year earlier, with the FY2026 full-year figure at -$12.2 million, down 124.19% from the prior year.
- Change in Inventory rose to $3.4 million in Q2 2026 per EXEL's latest filing, from -$13.8 million in the prior quarter.
- Across five years, Change in Inventory topped out at $8.4 million in Q1 2023 and bottomed at -$13.8 million in Q1 2026.
- The 5-year median for Change in Inventory is $1.5 million (2022), against an average of $610058.8.
- Biggest YoY gain for Change in Inventory was 4673.24% in 2026; the steepest drop was 399.86% in 2026.
- Year by year, Change in Inventory stood at $1.8 million in 2022, then sank by 182.62% to -$1.5 million in 2023, then jumped by 125.16% to $384000.0 in 2024, then soared by 980.47% to $4.1 million in 2025, then declined by 18.32% to $3.4 million in 2026.
- Per Business Quant, the three latest EXEL Change in Inventory figures stand at $3.4 million (Q2 2026), -$13.8 million (Q1 2026), and $4.1 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 71.84 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Exelixis | 14.44 Bn | 13.66 Bn | 590.86 Mn | 3.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 3.39 Mn |
| Apr 3, 2026 | 3.39 Mn |
| Jan 2, 2026 | -13.81 Mn |
| Jan 2, 2026 | -13.81 Mn |
| Oct 3, 2025 | 4.15 Mn |
| Oct 3, 2025 | 4.15 Mn |
| Jul 4, 2025 | -2.64 Mn |
| Jul 4, 2025 | -2.64 Mn |
| Apr 4, 2025 | 71,000.00 |
| Apr 4, 2025 | 71,000.00 |
| Jan 3, 2025 | -2.76 Mn |
| Jan 3, 2025 | -2.76 Mn |
| Sep 27, 2024 | 384,000.00 |
| Sep 27, 2024 | 384,000.00 |
| Jun 28, 2024 | -1.36 Mn |
| Jun 28, 2024 | -1.36 Mn |
| Mar 29, 2024 | -1.72 Mn |
| Mar 29, 2024 | -1.72 Mn |
| Dec 29, 2023 | -1.53 Mn |
| Dec 29, 2023 | -1.53 Mn |